VIR Biotechnology (VIR) Institutional Ownership
13F filers reported holding 13.1% of VIR Biotechnology (VIR) shares as of Sep 30, 2026, across 104 filers.
- Held by 13F filers
- 13.1%
- Sep 30, 2026
- 13F filers
- 104
- quarter ended Sep 30, 2026
- 13F value
- $251.4M
- 22.5M shares
- Quarter's fund flow
- Mild accumulation
- 22 new · 4 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Disposed · Open-market sale | 2,407Common Stock | $11.10 | ↗ |
| Nov 2, 2026 | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Disposed · Open-market sale | 1,343Common Stock | $11.33 | ↗ |
| Oct 27, 2026 | Topalian Suzanne Louise | director | Acquired · Grant / award | 8,000Common Stock | — | ↗ |
| Oct 27, 2026 | Topalian Suzanne Louise | director | Acquired · Grant / award | 4,731Common Stock | — | ↗ |
| Oct 27, 2026 | Topalian Suzanne Louise | director | Acquired · Grant / award | 16,000Stock Option (Right to Buy) | — | ↗ |
| Oct 27, 2026 | Topalian Suzanne Louise | director | Acquired · Grant / award | 9,462Stock Option (Right to Buy) | — | ↗ |
| Aug 11, 2026 | MORE ROBERT J | director | Disposed · Other | 8,000 | — | ↗ |
| Aug 11, 2026 | MORE ROBERT J | director | Acquired · Other | 8,000 | — | ↗ |
| Jun 9, 2026 | Coughlin Timothy P | director | Acquired · Grant / award | 8,000Common Stock | — | ↗ |
| Jun 9, 2026 | Coughlin Timothy P | director | Acquired · Grant / award | 8,000Common Stock | — | ↗ |
| Jun 9, 2026 | Coughlin Timothy P | director | Acquired · Grant / award | 16,000Stock Option (Right to Buy) | — | ↗ |
| Jun 9, 2026 | Coughlin Timothy P | director | Acquired · Grant / award | 16,000Stock Option (Right to Buy) | — | ↗ |
| Jun 1, 2026 | Napolitano Janet | director | Disposed · Open-market sale | 3,200 | $9.45 | ↗ |
| Jun 1, 2026 | Sabatini Brent | SVP, Chief Accounting Officer | Disposed · Open-market sale | 379Common Stock | $9.45 | ↗ |
| May 27, 2026 | Sigal Charles Elliott | director | Acquired · Grant / award | 8,000 | — | ↗ |
| May 27, 2026 | Sigal Charles Elliott | director | Acquired · Grant / award | 16,000Stock Option (Right to Buy) | — | ↗ |
| May 27, 2026 | Napolitano Janet | director | Acquired · Grant / award | 8,000 | — | ↗ |
| May 27, 2026 | Napolitano Janet | director | Acquired · Grant / award | 16,000Stock Option (Right to Buy) | — | ↗ |
| May 27, 2026 | MORE ROBERT J | director | Acquired · Grant / award | 8,000 | — | ↗ |
| May 27, 2026 | MORE ROBERT J | director | Acquired · Grant / award | 16,000Stock Option (Right to Buy) | — | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of VIR Biotechnology do institutions hold?
13F filers reported holding 13.1% of VIR Biotechnology's shares as of Sep 30, 2026, across 104 filers.
How many 13F filers hold VIR Biotechnology?
VIR Biotechnology was held by 104 13F filers as of Sep 30, 2026.
Not investment advice.

